News
Nonacus introduces its first ultrasensitive qPCR assay for ESR1 mutation detection
Nonacus Ltd, has launched GALEAS uPCR ESR1, an ultrasensitive qPCR (uPCR) assay developed to detect eleven mutations in the ESR1 gene which are known to be associated with resistance to endocrine therapy October 31, 2024 | COMPANY | NEWS | ONCOLOGY Endocrine therapy is the main therapeutic option for estrogen receptor-positive (ER+), HER2 negative (HER2-) breast cancers, which account…
Read More about Nonacus introduces its first ultrasensitive qPCR assay for ESR1 mutation detectionNonacus achieves ISO 27001 certification for GALEAS software
Nonacus Ltd is proud to announce that it has achieved ISO 27001 certification for its innovative cloud-based GALEAS software and panel design tool. October 22, 2024 | COMPANY | NEWS Nonacus, a provider of innovative genomic products including GALEAS a cloud-based software, is proud to announce that it has achieved ISO 27001 certification, the international standard for…
Read More about Nonacus achieves ISO 27001 certification for GALEAS softwareEMQN CIC partners with Informed Genomics to validate clinical laboratory results
September 24, 2024 | COMPANY | NEWS | ONCOLOGY 24 September 2024, Birmingham UK – Informed Genomics, the UK-based genomic testing laboratory delivering innovative ISO accredited services, has been selected by EMQN CIC to provide tumour profiling to support its quality assurance services. Informed Genomics offers comprehensive next-generation sequencing (NGS) cancer mutation analyses from solid tumour and cell-free DNA…
Read More about EMQN CIC partners with Informed Genomics to validate clinical laboratory resultsNonacus Awarded All Wales Medical Genomics Service (AWMGS) Tender for Familial Hypercholesterolaemia Testing
Written by Saba Shamsuddin SEPT 24, 2024 | COMPANY | NEWS Nonacus Ltd, a leading provider of ultra-sensitive next-generation sequencing (NGS) products, has been awarded the NHS All Wales Medical Genomic Services (AWMGS) tender for familial hypercholesterolemia (FH) testing. The new contract involves the supply of Nonacus’ NGS custom-designed panels for clinical use in FH testing. This…
Read More about Nonacus Awarded All Wales Medical Genomics Service (AWMGS) Tender for Familial Hypercholesterolaemia TestingNHS Trusts evaluate GALEAS™ Bladder cancer testing service
September 4, 2024 | COMPANY | NEWS | ONCOLOGY Service from Informed Genomics could save NHS tens of millions every year, speed up waiting times and test thousands of patients without a hospital visit 4 September 2024, Birmingham UK – Informed Genomics, the UK-based genomic testing laboratory delivering innovative ISO accredited services, has announced a partnership with five NHS…
Read More about NHS Trusts evaluate GALEAS™ Bladder cancer testing serviceHow public/private partnerships in genomics are streamlining patient pathways and delivering value
July 15, 2024 | COMPANY | NEWS | ONCOLOGY Since the completion of the Human Genome Project in 2003, there has been huge growth in the utilisation of genomics, but how can partnerships in this area be used to improve patient experience? This is the topic covered by our CEO Simon Davis in the summer edition of ‘Innovations in…
Read More about How public/private partnerships in genomics are streamlining patient pathways and delivering valueDelivering NGS research services for European healthcare providers
Juny 14, 2024 | COMPANY | NEWS | ONCOLOGY The recent ESHG 2024 event in Berlin provided us with a great opportunity to meet up with new and existing contacts from across Europe. Our global customer base includes major healthcare providers, universities, hospitals and research centres across the continent, so it was great to hear more about the challenges…
Read More about Delivering NGS research services for European healthcare providersTransforming cancer healthcare through public private partnerships
Juny 12, 2024 | COMPANY | NEWS | ONCOLOGY Transforming cancer healthcare through public-private partnerships Informed Genomics is the Most Innovative Genomic Testing Company 2024 – England, that’s according to the latest edition of Global Health & Pharma magazine. To help celebrate our success, the Q2 version of the magazine has run an article by our CEO Simon Davis…
Read More about Transforming cancer healthcare through public private partnershipsMay 30, 2024 | COMPANY | NEWS | ONCOLOGY To help increase understanding of bladder cancer during bladder cancer awareness month, Uwais Mufti, consultant urologist at Leeds Teaching Hospitals NHS Trust, gives us three top facts about bladder cancer – and highlights a symptom that should not be ignored! Bladder cancer is not a rare cancer. It is the…
Read More about Three things you should know about bladder cancerHereditary Cancer Services solve challenges for breast surgeons
May 21, 2024 | COMPANY | NEWS | ONCOLOGY Our Review of the Association of Breast Surgery Annual Conference, 13-14th May 2024 As the voice of breast surgery in the UK, the Association of Breast Surgery’s (ABS) conferences and educational meetings promote good practice through information sharing and networking. And this year’s Annual Conference was no exception. With a…
Read More about Hereditary Cancer Services solve challenges for breast surgeons